Expression of human coagulation factor VIII in a human hybrid cell line, HKB11

Molecular Biotechnology

Volumn 34, Issue 2, 2006, Pages 165-178

  Mei, Baisong ^a   Chen, Yaoqi ^a   Chen, Jianmin ^a   Pan, Clark Q ^b   Murphy, John E ^a  

^a Expression Technologies   (United States)

^b Formulation and Freeze Dry   (United States)

Author keywords

Bcl 2; Bcl xL; Coagulation factor VIII; HKB11; Hsp70; Human cell line; Protein secretion

Indexed keywords

CELLS; COAGULATION; DNA; PROTEINS;

HUMAN CELL LINE; HUMAN COAGULATION FACTOR; IMMUNOFLUORESCENCE STAINING; PROTEIN SECRETION;

CLONING;

BLOOD CLOTTING FACTOR 8; HEAT SHOCK PROTEIN 70; PROTEIN BCL 2; PROTEIN BCL XL;

CELL CLONE; CELL LINE; CELL LINE HKB11; CELL STRAIN BHK; CELL STRAIN HEK293; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; WESTERN BLOTTING;

BCL-X PROTEIN; BIOTECHNOLOGY; BLOTTING, WESTERN; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FLOW CYTOMETRY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS;

MAMMALIA;

EID: 33845923722     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:34:2:165     Document Type: Conference Paper

References (51)

1. Gitschier, J., Wood, W. I., Goralka, T. M., et al. (1984) Characterization of the human factor VIII gene. Nature 312, 326-330.
2. Toole, J. J., Knopf, J. L., Wozney, J. M., et al. (1984) Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312, 342-347.
3. Vehar, G. A., Keyt, B., Eaton, D., et al. (1984) Structure of human factor VIII. Nature 312, 337-342.
4. Wood, W. I., Capon, D. J., Simonson, C. C., et al. (1984) Expression of active human factor VIII from recombinant DNA clones. Nature 312, 330-337.
5. Andersson, L. O., Forsman, N., Huang, K., et al. (1986) Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryopricitate, and plasma. PNAS USA 83, 2979-2983.
6. Eaton, D. L., Hass, P. E., Riddle, L., et al. (1987) Characterization of recombinant human factor VIII. J. Biol. Chem. 262, 3285-3290.
7. Kaufman, R. J., Wasley, L. C., and Dorner, A. J. (1988) Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263, 6352-6362.
8. Toole, J. J., Pittman, D. D., Orr, E. C., Murtha, P., Wasley, L. C., and Kaufman, R. J. (1986) A large region (approximately equal to 95 kDa) of human factor VIII is dispensible for in vitro procoagulation activity. PNAS USA 83, 5939-5942.
9. Lind, P., Larsson, K., Spira, J., et al. (1995) Novel form of B-domain-deleted recombinant factor VIII molecules; construction and biochemical characterization. Eur. J. Biochem. 232, 19-27.
10. Lusher, J. M., Lee, C. A., Kessler, C .M., and Bedrosian, C. L. (2003) The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe hemophilia A. Hemophilia 9, 38-49.
11. Lenting, P. J., van Mourik, J. A., and Mertens, K. (1998) The life cycle of coagulation factor VIII in view of its structure and function. Blood 92, 3983-3996.
12. Kaufman, R. J., Pipe, S. W., Tagliavacca, L., Swaroop, M., and Moussalli, M. (1997) Biosynthesis, assembly and secretion of coagulation factor VIII. Blood. Coagul. Fibrinolysis. 8, S3-S14.
13. Kaufman, R. J., Wasley, L. C., Davies, M. V., Wise, R. J., Israel, D. I., and Dorner, A. J. (1989) Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol. Cell Biol. 9, 1233-1242.
14. Lynch, C. M., Israel, D. I., Kaufman, R. J., and Miller, A. D. (1993) Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum. Gene Ther. 4, 259-272.
15. Hoeben, R. C., Fallaux, F. J., Cramer, S. J., et al. (1995) Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer in its coding region. Blood 85, 2447-2454.
16. Plantier, J. -L., Guillet, B., Ducasse, C. et al. (2005) B-domain deleted factor VIII is aggregated and degraded through proteasomal and lysosomal pathways. Thromb. Haemost. 93, 824-832.
17. Marquette, K. A., Pittman, D. D., and Kaufman, R. J. (1995) A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells. J. Biol. Chem. 270, 10,297-10,303.
18. Nichols, W. C., Seligsohn, U., Zivellin, A., et al. (1998) Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93, 61-70.
19. Pipe, S. W., Morris, J. A., Shah, J., and Kaufman, R. J. (1998) Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J. Biol. Chem. 273, 8567-8544.
20. Cho, M. -S., Yee, H., and Chan, S. (2002) Establishment of a human somatic hybrid cell line for recombinant protein production. J. Biomed. Sci. 9, 631-638.
21. Cho, M. -S., Yee, H., Brown, C. L., Mei, B., Mirenda, C. A., and Chan, S. (2003) A versatile expression system for rapid and stable production of recombinant proteins. Bioengineering Progress 19, 229-232.
22. Pittman, D. D., Marquette, K. A., and Kaufman, R. J. (1994) Role of the B-domain for factor VIII and factor V expression and function. Blood 84, 4214-4225.
23. Rutkowski, D. T. and Kaufman, R. J. (2004) A trip to the ER: coping with stress. Trends Cell Biol. 14, 20-28.
24. Frydman, J. (2001) Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu. Rev. Biochem. 70, 603-647.
25. Mayer, M. P., Brehmer, D., Gassler, C. S., and Bukau B. (2001) Hsp70 chaperone machines. Adv. Protein Chem. 59, 1-44.
26. Ryan, M. T. and Pfanner, N. (2001) Hsp70 proteins in protein translocation. Adv. Protein Chem. 59, 223-242
27. Ailor, E. and Betenbaugh, M. J. (1998) Overexpression of a cytosolic chaperone to improve solubility and secretion of a recombinant IgG protein in insect cells. Biotechnol. Bioeng. 58, 196-203.
28. Mosser, D. D., Caron, A. W., Gourget, L., et al. (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell Biol. 20, 7146-7159.
29. Soukharev, S., Hammond, D., Ananyeva, N. M., et al. (2002) Expression of factor VIII in recombinant and transgenic systems. Blood Cells, Molecules, and Diseases 28, 234-248.
30. Swaroop, M., Moussalli, M., Pipe, S. W., and Kaufman, R. J. (1997) Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J. Biol. Chem. 272, 24,121-24,124.
31. Miao, H. Z., Sirachainan, N., Palmer, L., et al. (2004) Bioengineering of coagulation factor VIII for improved secretion. Blood 103, 3412-3419.
32. Zhang, B., Kaufman, R. J., and Ginsburg, D. (2005) LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J. Biol. Chem. 280, 25,881-25,886.
33. Herlitschka, S. E., Schlokat, U., Falkner, F. G., and Dorner, F. (1998) High expression of a B-domain deleted factor VIII gene in a human hepatic cell line. J. Biotech. 61, 165-173.
34. Chen, C., Fang, X. -D., Zhu, J., and Wu, X. -F. (1999) The gene expression of coagulation factor VIII in mammalian cell lines. Thrombosis Research 95, 105-115.
35. Wion, K. L., Kelly, D., Summerfield, J. A., Tuddenham, E. G., and Lawn, R. M. (1985) Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317, 726-729.
36. Do, H., Healey, J. F., Waller, E. K., and Lollar, P. (1999) Expression of factor VIII by murine liver sinusoidal endothelial cells. J. Biol. Chem. 274, 19,587-19,592.
37. Hollestelle, M. J., Thinnes, T., Crain, K., et al. (2001) Tissue distribution of factor VIII gene expression in vivo: a closer look. Thromb. Haemost. 86, 855-861.
38. Hollestelle, M. J., Poyck, P. P., Hollestelle, J. M., Marsman, H. A., Mourik, J. A., and Gulik, T. M. (2005) Extra-hepatic factor VIII expression in porcine fulminant hepatic failure. J. Thromb. Haemost. 3, 2274-2280.
39. Pittman, D. D., Alderman, E. M., Tomkinson, K. N., Wang, J. H., Giles, A. R., and Kaufman, R. J. (1993) Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81, 2925-2935.
40. Tagliavacca, L., Wang, Q., and Kaufman, R. J. (2000) ATP-dependent dissociation of non-disulfide-linked aggregates of coagulation FVIII is a rate-limiting step for secretion. Biochemistry 39, 1973-1981.
41. Becker, S., Simpson, J. C., Pepperkok, R., et al. (2004) Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells. Thromb. Haemost. 92, 23-35.
42. Dorner, A. J., Wasley, L. C., and Kaufman, R. J. (1992) Overexpression of GRP78 mitigates stress induction of glucose regulated proteins and blocks secretion of selective proteins in Chinese hamster ovary cells. EMBO J. 11, 1563-1571.
43. Young, J. C., Agashe, V. R., Siegers, K., and Hartl, F. U. (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 5, 781-791.
44. Nollen, E. A. A. and Morimoto, R. I. (2002) Chaperone signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J. Cell Sci. 115, 2809-2816.
45. Smales, C. M., Dinnis, D. M., Stansfield, S. H., et al. (2004) Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol. Bioeng. 88, 474-488.
46. Lasunskaia, E. B., Fridlianskaia, I. I., Darieva, Z. A., da Silva, M. S. R., Kanashiro, M. M., and Margulis, B. A. (2003) Transfection of NS0 myeloma fusion partner cells with hsp70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis. Biotechnol. Bioeng. 8, 496-504.
47. Borner, C. (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39, 615-647.
48. Tey, R. T., Singh, R. P., Piredda, L., Piacentini, M., and Al-Rubeai, M. (2000) Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. J. Biotechnol. 79, 147-159.
49. Jung, D., Cote, S., Drouin, M., Simard, C., and Lemieux, R. (2002) Inducible expression of Bcl-xL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures. Biotechnol. Bioeng. 79, 180-187.
50. Dinnis, D. M. and James, D. C. (2005) Engineering mammalian cell factories for recombinant monoclonal antibody production: lessons form nature? Biotechnol. Bioeng. 91, 180-189.
51. Wlaschin, K. F., Nissom, P. M., Gatti Mde, L., et al. (2005) EST sequencing for gene discovery in Chinese hamster ovary cells. Biotechnol. Bioeng. 91, 592-606.